Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results

被引：0
|
作者：
Michael Kellner
Christoph Muhtz
Kristina Stark
Alexander Yassouridis
Josef Arlt
Klaus Wiedemann
机构：
[1] University Hospital Hamburg-Eppendorf,Department of Psychiatry and Psychotherapy
[2] Max Planck Institute of Psychiatry,undefined
来源：
Psychopharmacology | 2005年 / 179卷
关键词：
Metabotropic glutamate receptors; CCK-4; Panic; Anxiety; LY544344; ACTH; Cortisol; Prolactin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：310 / 315
页数：5
相关论文
共 50 条
  • [1] Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans:: preliminary results
    Kellner, M
    Muhtz, C
    Stark, K
    Yassouridis, A
    Arlt, J
    Wiedemann, K
    PSYCHOPHARMACOLOGY, 2005, 179 (01) : 310 - 315
  • [2] Effects of the metabotropic glutamate type II receptor agonist LY544344 on panic anxiety induced by cholecystokinin tetrapeptide in healthy volunteers
    Kellner, M
    Muhtz, C
    Stark, K
    Yassouridis, A
    Wiedemann, K
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 253 - 253
  • [3] Effects of the metabotropic glutamate type II receptor agonist LY544344 on panic anxiety induced by cholecystokinin tetrapeptide in healthy volunteers
    Kellner, M
    Muhtz, C
    Yassouridis, A
    Stark, K
    Arlt, J
    Wiedemann, K
    EUROPEAN PSYCHIATRY, 2005, 20 : S174 - S174
  • [4] Effects of the metabotropic glutamate type II agonist LY544344 on panic and anxiety induced by cholecystokinin tetrapeptide (CCK-4)
    Kellner, M
    Muhtz, C
    Yassouridis, A
    Stark, K
    Arlt, J
    Bieck, P
    Wiedemann, K
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S369 - S369
  • [5] Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: In vivo pharmacology of LY544344
    Rorick-Kehn, LM
    Perkins, EJ
    Knitowski, KM
    Hart, JC
    Johnson, BG
    Schoepp, DD
    McKinzie, DL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02): : 905 - 913
  • [6] A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740
    Bond, A
    Monn, JA
    Lodge, D
    NEUROREPORT, 1997, 8 (06) : 1463 - 1466
  • [7] mGlu2/3 receptor agonist (LY354740) in anxiety
    Schoepp, Darryle D.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 242
  • [8] Effects of the group II metabotropic glutamate receptor agonist, LY354740 on schedule-controlled behaviour in rats
    Moore, NA
    Rees, G
    Monn, JA
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (03): : 319 - 325
  • [9] Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans
    Grillon, C
    Cordova, J
    Levine, LR
    Morgan, CA
    PSYCHOPHARMACOLOGY, 2003, 168 (04) : 446 - 454
  • [10] Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans
    Christian Grillon
    Jeremy Cordova
    Louise R. Levine
    Charles A. Morgan, III
    Psychopharmacology, 2003, 168 : 446 - 454
12345